Attached files

file filename
EX-99.1 - ARROGENE, INCreorganizationagmtfinal4.htm

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549



FORM 8-K


CURRENT REPORT



Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): July 18, 2011



SRKP 16, INC.

(Exact name of registrant as specified in its charter)



Delaware

(State or other jurisdiction of

incorporation or organization)

000-53018

Commission File Number

20-8057585

(I.R.S. Employer

Identification Number)


4737 North Ocean Drive, Suite 207

Lauderdale by the Sea, FL 33308

(Address of principal executive offices)


(310) 203-2902

(Issuer’s Telephone Number)


______________________________________________________

(Former name or former address, if changed since last report)




___

Written communications pursuant to Rule 425 under the Securities Act

___

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

___

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

___

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act






ITEM 1.01

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT



        Effective July 18, 2011, SRKP 16, Inc., a Delaware corporation (the “Company”) entered into an Agreement and Plan of Reorganization (“Agreement”), between the Company and Arrogene NanoTechnology, Inc., a California corporation (“Arrogene”), pursuant to which, if consummated, the Company would acquire 100% of the issued and outstanding shares of common stock of Arrogene in exchange for shares of common stock of the Company.  If consummated, the transaction will result in a change of control of the Company.


Consummation of the acquisition is subject to the satisfaction of numerous conditions, including the completion of an audit of the financial statement of the acquired companies, complete and satisfactory due diligence, the consummation of a private offering of securities by the Company, completion of the acquisition of an IP license by Arrogene, and other conditions customary in transactions of this nature.  No prediction has been made as to when the transaction can or will be consummated.


 A copy of the Agreement is filed herewith as Exhibit 99.1



ITEM 9.01:     FINANCIAL STATEMENTS AND EXHIBITS


 

(c)

Exhibit

 

 

 

 

 

Item

Title

 

 

 

 

99.1

Agreement and Plan of Reorganization dated July 18, 2011

 

 

 

 

 

 



SIGNATURE


        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



 

 

SRKP 16, Inc.


Date:   _October 25, 2011

By: _/s/ Richard A. Rappaport_______

     Richard A. Rappaport, President

 

 




2